Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 4Phase 1/2 3

Status

Recruiting 3Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 5UNKNOWN 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Nasopharyngeal Carcinoma 20Carcinoma, Non-Small-Cell Lung 18Esophageal Squamous Cell Carcinoma 15Breast Neoplasms 14Triple Negative Breast Neoplasms 13Squamous Cell Carcinoma of Head and Neck 11Carcinoma, Hepatocellular 11Stomach Neoplasms 8Small Cell Lung Carcinoma 8Uterine Cervical Neoplasms 6Recurrence 6Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Transitional Cell 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Neoplasm Metastasis 4Melanoma 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Locally Advanced Rectal Cancer 3Liver Neoplasms 3Turcot syndrome 2Pathologic Complete Response 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2

Interventions

Bevacizumab 233Fluorouracil 219Oxaliplatin 215Irinotecan 215Leucovorin 198Capecitabine 153Cetuximab 145Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15apatinib 14Gemcitabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × toripalimab × Clear all
NCT06903858 2026-05-22

PICC-3

Sun Yat-sen University

Phase 2 Recruiting
105 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting
270 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT07106034 2025-08-12

ONTOP

Shanghai Pudong Hospital

Phase 2 Not yet recruiting
32 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06547203 2024-08-09

Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study

Sun Yat-sen University

Phase 2 Recruiting
34 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04653480 2023-07-17

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

Zhejiang University

Phase 2 Unknown
61 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03927898 2019-04-25

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡